Financhill is a comprehensive financial analysis platform that provides stock analysis, market data, investment tools, and educational resources to help investors make informed decisions.

How do I get started with Financhill?

You can start by creating a free account, exploring our stock analysis tools, setting up a watchlist, or trying our 7-day trial for full access to all premium features.

What features does Financhill offer?

Financhill offers stock analysis, technical charts, fundamental data, earnings information, dividend tracking, portfolio management, market screening tools, and educational resources.

How accurate are stock forecasts?

Stock forecasts are based on technical and fundamental analysis but should not be considered as guaranteed predictions. Past performance does not guarantee future results.

How do I analyze TVTX stock?

Use our comprehensive analysis tools including technical charts, fundamental metrics, earnings data, and Stock Score to evaluate TVTX investment potential.

What is TVTX stock price today?

Get real-time TVTX stock price, historical data, and price charts on Financhill. Track TVTX performance with our advanced analysis tools.

Is TVTX a good investment?

Evaluate TVTX investment potential using our Stock Score, fundamental analysis, technical indicators, and earnings data. Consider your risk tolerance and investment goals.

How to buy TVTX stock?

To buy TVTX stock, open a brokerage account, research the company using our analysis tools, and place your order through your broker. Always do your own research before investing.

What is the market cap of TVTX?

View detailed market capitalization data and company valuation metrics for TVTX on our comprehensive analysis page.

What is the P/E ratio of TVTX?

Use our fundamental analysis tools to view TVTX P/E ratio and compare valuation metrics with industry peers.

What are TVTX earnings?

View TVTX earnings data, quarterly results, revenue growth, and profit margins on our comprehensive earnings analysis page. Track earnings trends and analyst estimates.

Back

Travere Therapeutics, Inc. Stock Predictions

Missed $0.81? RAD Intel Now Open at $0.85/Share

DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi

Buy

TVTX
Travere Therapeutics, Inc.

Last Price:

$35.3300

Seasonality Move:

27.99%

7 Day Trial

ALL ACCESS PASS

$ 7

$0.85 Entry Open - Fortune 1000 AI Tech in Demand

Travere Therapeutics, Inc. Stock Forecast

Over the next 52 weeks, Travere Therapeutics, Inc. has on average historically risen by 1547.4% based on the past 22 years of stock performance.
Travere Therapeutics, Inc. has risen higher in 11 of those 22 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
Is Travere Therapeutics, Inc. Stock Undervalued?

The current Travere Therapeutics, Inc. [TVTX] share price is $34.8500. The Score for TVTX is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
TVTX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.

Will Travere Therapeutics, Inc. Stock Go Up Next Year?

Over the next 52 weeks, Travere Therapeutics, Inc. has on average historically risen by 1547.4% based on the past 22 years of stock performance.

Travere Therapeutics, Inc. Stock Rating

Buy

Travere Therapeutics, Inc. (TVTX) is a Buy

Is Travere Therapeutics, Inc. overpriced?

Travere Therapeutics, Inc. has risen higher in 11 of those 22 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%

Travere Therapeutics, Inc. Stock Price History

Is TVTX stock going to rise?

Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TVTX is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:

NASDAQ

Country:

United States

Industry:

Biotechnology

Sector:

Health Care

Type:

stock

Website:

travere.com

52-Week Data

52-Week High:

37.5000

52-Week Low:

12.9100

Prediction Charts

Market Cap:

3.1B

Price in USD:

34.8500

Volume:

1.4M

Beta:

52.6209

Technical Analysis

SMA50:

30.3975

SMA100:

24.6012

SMA200:

21.0811

52-Wk Change:

79.82%

Stock Predictions

Is Travere Therapeutics, Inc. stock public?

Yes, Travere Therapeutics, Inc. is a publicly traded company.
What is the Travere Therapeutics, Inc. stock quote today?

The Travere Therapeutics, Inc. stock price is 34.8500 USD today.
How to buy Travere Therapeutics, Inc. stock online?

You can buy Travere Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date	Opening	Closing	Minimum	Maximum
Nov-13	36.2600	33.8900	36.4150	33.7300
Nov-14	33.1400	34.4950	35.3190	33.0500
Nov-17	34.5800	35.4300	35.8200	34.2800
Nov-18	35.2450	35.9800	36.8700	34.7700
Nov-19	35.9400	35.4400	36.7700	35.3600
Nov-20	36.3300	34.7400	36.6500	34.1820
Nov-21	34.7000	34.6900	35.4576	34.3500
Nov-24	35.2650	35.7700	36.4000	35.0200
Nov-25	35.6300	36.0100	36.5300	35.3100
Nov-26	36.0100	36.2700	36.5790	35.4700
Nov-28	36.8700	35.4100	37.5000	35.3100
Dec-1	34.9350	35.1900	35.5000	34.5700
Dec-2	35.5000	33.9900	35.6400	33.4500
Dec-3	34.4100	34.8500	35.3500	34.1000

Travere Therapeutics, Inc. Earnings

Travere Therapeutics, Inc. Earnings Report: Per Share Travere Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.

Travere Therapeutics, Inc. Forecast Revenue Growth

Travere Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for Travere Therapeutics, Inc. and historical quarterly revenue growth:

Analysts estimate an earnings increase this quarter of $0.54 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.58 per share, and an increase next year of $1.08 per share.

* Travere Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.